Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins.

Patients with locally advanced non-small cell lung cancer infiltrating the left atrium (LA) or the intrapericardial base of the pulmonary veins (PVs) are generally not considered good candidates for surgery because of the poor long-term survival. In the last 10 years, 31 consecutive patients with non-small cell lung cancer directly invading the LA or the intrapericardial base of the PVs underwent surgery. Pneumonectomy was the operation performed most frequently. In-hospital mortality was 9.7% and overall morbidity was 52%. One-, 2- and 3-year survival rates were 64, 46 and 30%, respectively with a mean survival of 22 months. The systemic recurrence of disease was the major cause of death at follow-up. At statistical analyses, the N-factor and the type of operation were related to poor long-term survival. In these patients, surgery could be performed with an acceptable operative mortality and morbidity. Surgery should be considered whenever a complete resection is technically possible. A careful preoperative evaluation is mandatory to select good candidates for surgery.

[1]  P. Granone,et al.  Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  B. Grand,et al.  Lung cancer invading the pericardium: quantum of lymph nodes. , 2010, The Annals of thoracic surgery.

[3]  Jian-Hua Fu,et al.  Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer. , 2009, The Annals of thoracic surgery.

[4]  L. Tanoue,et al.  The new lung cancer staging system. , 2009, Chest.

[5]  P. Dartevelle,et al.  Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. , 2008, The Annals of thoracic surgery.

[6]  R. Rami-Porta,et al.  ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  P. Dartevelle,et al.  Long-term results after carinal resection for carcinoma: does the benefit warrant the risk? , 2006, The Journal of thoracic and cardiovascular surgery.

[8]  G. Pelosi,et al.  Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. , 2005, The Annals of thoracic surgery.

[9]  P. Bruzzi,et al.  Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. , 2004, The Annals of thoracic surgery.

[10]  M. Kris,et al.  Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. , 2001, The Annals of thoracic surgery.

[11]  R. Giudicelli,et al.  Is lung cancer surgery justified in patients with direct mediastinal invasion? , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  A. Bernard,et al.  Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  T. Fukuse,et al.  Extended operation for non-small cell lung cancer invading great vessels and left atrium. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  V. Rusch,et al.  Management of non-small cell lung cancer with direct mediastinal involvement. , 1994, The Annals of thoracic surgery.

[15]  P. Dartevelle,et al.  Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer. , 1994, The Annals of thoracic surgery.